Skip to Content Skip to Navigation

Registration
Information
Webinar Series

Professor Ross Hannan

Non-Executive Director
Appointed May 2017

Experience and Expertise

Professor Ross Hannan is the Deputy Dean (Research) of the College of Health and Medicine at ANU and an internationally recognised research scientist, whose work on ribosome biogenesis has led to new treatment paradigms in cancer. He received his PhD from the University of Tasmania in 1994, before undertaking postdoctoral research in the USA. Ross’s far-reaching research contributions have been recognised by his appointment as inaugural Centenary Chaired Professor in Cancer Research at the Australian National University and Fellow of the Australian Academy of Health and Medical Sciences.

Committees

  • Co-Chair, Research Advisory Committee.

 

Professor Grant McArthur

Non-Executive Director
Appointed March 2022

Experience and Expertise

Professor Grant McArthur is a Medical Oncologist, Fellow of the Royal Australasian College of Physicians and holds a PhD in Medical Biology. He is the Chief Executive Officer of the VCCC Alliance; inaugural Lorenzo Galli Chair of Melanoma and Skin Cancers at the University of Melbourne; Head, Molecular Oncology Laboratory and Senior Consultant Medical Oncologist at the Peter MacCallum Cancer Centre.

Grant was the inaugural winner of the Translational Research Award of the Foundation Nelia et Amadeo Barletta; held the Sir Edward Dunlop Clinical Cancer Research Fellowship of the Cancer Council of Victoria; won the inaugural Martin Lackmann medal for translational research; received the Medical Oncology Group of Australia, Novartis Oncology Cancer Achievement Award and has been the recipient of the prestigious Tom Reeve Award from the Clinical Oncology Society of Australia. He is the national and international study co-chair of a number of clinical trials of targeted therapies and has published over 300 papers including senior or first author publications in many leading global medical journals.

In 2023, Grant was awarded an Officer of the Order of Australia (AO) in recognition of his distinguished service to medicine as a clinician scientist through melanoma and cancer research, and through his leadership roles.

Committees

  • Co-Chair, Research Advisory Committee.

 

Leonie Young

Leonie Young

Experience and Expertise

Leonie Young DUniv was diagnosed with breast cancer in 1987. Since her diagnosis she has been involved with many aspects of cancer patient/consumer advocacy, support, training, and mentoring. Leonie is the President of Reach to Recovery International, a global organisation working with its members and collaborators to influence change and improve the quality of life of people affected by breast cancer. She is the Peer Support Coordinator for the Wesley Hospital Choices Cancer Support Centre (Australia); co-founder and co-facilitator of EveryCloud Consumer and Researcher Advocacy Training Programs; and holds a position as Honorary Research Fellow with Wesley Medical Research (Australia). Leonie is a member of several national and international cancer focused organisations and committees including the National Breast Cancer Foundation Research Advisory Committee. She is the recipient of an Honorary Degree of Doctor of the University, Griffith University (Australia, 2018), and the Reach to Recovery International Terese Lasser Award (2019) both in recognition of distinguished service to the community, particularly as an advocate for women diagnosed with breast cancer.

 

Dr Alison Evans

Experience and Expertise

Dr Alison Evans is a strategic health consultant with almost 30 years of experience in health and research strategy and communication. She is a trusted partner for many government, non-profit and corporate organisations across Australia and has led the development of national and state-based cancer programs and research strategies. Alison is delighted to be supporting the National Breast Cancer Foundation in the development and implementation of the Pink Horizon Research Strategy.

 

For more information on our Pink Horizon Research Strategy click here.